The NSAID roller coaster: more about rofecoxib.
作者信息
Aronson J K
出版信息
Br J Clin Pharmacol. 2006 Sep;62(3):257-9. doi: 10.1111/j.1365-2125.2006.02761.x.
Abstract
摘要
相似文献
1
The NSAID roller coaster: more about rofecoxib.
Br J Clin Pharmacol. 2006 Sep;62(3):257-9. doi: 10.1111/j.1365-2125.2006.02761.x.
2
[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].
Yao Xue Xue Bao. 2005 Nov;40(11):967-9.
3
Balancing the cyclooxygenase portfolio.
CMAJ. 2006 May 23;174(11):1581-2. doi: 10.1503/cmaj.060471.
4
NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib.
Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1134-42. doi: 10.1002/pds.1826.
5
Rofecoxib and clinically significant gastrointestinal events.
Am J Med Sci. 2011 Nov;342(5):438-9. doi: 10.1097/MAJ.0b013e31822f3ff4.
6
Concern about one drug or entire class of drugs.
Reumatizam. 2005;52(1):5-6.
7
The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.
J Anesth. 2006;20(4):348-51. doi: 10.1007/s00540-006-0432-7.
8
Co-administration of rofecoxib and tramadol results in additive or sub-additive interaction during arthritic nociception in rat.
Pharmacol Biochem Behav. 2007 Aug-Sep;87(3):331-40. doi: 10.1016/j.pbb.2007.05.007. Epub 2007 May 21.
9
Evaluating drug effects in the post-Vioxx world: there must be a better way.
Circulation. 2006 May 9;113(18):2173-6. doi: 10.1161/CIRCULATIONAHA.106.625749.
10
Cardiovascular effects of cyclooxygenase-2 inhibitors.
Curr Opin Gastroenterol. 2007 Nov;23(6):617-24. doi: 10.1097/MOG.0b013e3282f026a7.
引用本文的文献
1
Non-Steroidal Anti-Inflammatory Drugs in Orthopedic Outpatient Cases in a Tertiary Care Teaching Hospital: A Descriptive Cross-sectional Study.
JNMA J Nepal Med Assoc. 2021 Nov 15;59(243):1116-1119. doi: 10.31729/jnma.6767.
2
Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysis.
Br J Clin Pharmacol. 2009 Nov;68(5):647-50. doi: 10.1111/j.1365-2125.2009.03553.x.
3
Methods in clinical pharmacology.
Br J Clin Pharmacol. 2009 Jul;68(1):1-3. doi: 10.1111/j.1365-2125.2009.03485.x.
4
Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.
Drug Saf. 2009;32(2):99-110. doi: 10.2165/00002018-200932020-00003.
5
Editors' review of 2006 and the BJCP prize.
Br J Clin Pharmacol. 2007 Jan;63(1):1-4. doi: 10.1111/j.1365-2125.2007.02843.x.
本文引用的文献
1
The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in Scotland.
Br J Clin Pharmacol. 2006 Sep;62(3):366-8. doi: 10.1111/j.1365-2125.2006.02691.x.
2
Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships.
Br J Clin Pharmacol. 2006 Sep;62(3):358-65. doi: 10.1111/j.1365-2125.2006.02660.x.
3
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
Br J Clin Pharmacol. 2006 Sep;62(3):345-57. doi: 10.1111/j.1365-2125.2006.02653.x.
4
Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
Br J Clin Pharmacol. 2006 Jun;61(6):738-40. doi: 10.1111/j.1365-2125.2006.02678.x.
5
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors.
CMAJ. 2006 May 23;174(11):1563-9. doi: 10.1503/cmaj.051679. Epub 2006 May 2.
6
Prostaglandins, bioassay and inflammation.
Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S182-92. doi: 10.1038/sj.bjp.0706506.
7
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.
N Engl J Med. 2005 Mar 17;352(11):1081-91. doi: 10.1056/NEJMoa050330. Epub 2005 Feb 15.
8
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
N Engl J Med. 2005 Mar 17;352(11):1092-102. doi: 10.1056/NEJMoa050493. Epub 2005 Feb 15.
9
Obituary: John R. Vane (1927-2004).
Nature. 2005 Jan 6;433(7021):28. doi: 10.1038/433028a.
10
COX-3: fact or fancy?
Joint Bone Spine. 2004 Nov;71(6):451-3. doi: 10.1016/j.jbspin.2004.02.003.
Zotero 插件